LPL and nephrotic syndrome: Another intermediary in LPL deficiency is represented by ANGPTL4, a glycoprotein expressed in several tissues that physiologically inhibits LPL activity and is upregulated in nephrotic syndrome as emerging studies have demonstrated [82], thus contributing to hypertriglyceridemia pathogenesis.